ALEMTUZUMAB INDUCTION MAY INCREASE ANTIBODY-MEDIATED REJECTION IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
G. C. Wu, Kenneth V. Lieberman, L. M. Ettinger, Joan M. Abrams, MICHAEL E. SHAPIRO
Abstract
G. C. Wu, Kenneth V. Lieberman, L. M. Ettinger, Joan M. Abrams, MICHAEL E. SHAPIRO
Abstract
Wu, G. C.1; Lieberman, K. V.2; Ettinger, L. M.2; Abrams, J. M.3; Shapiro, M. E.3 Author Information
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Wu, G. C.1; Lieberman, K. V.2; Ettinger, L. M.2; Abrams, J. M.3; Shapiro, M. E.3 Author Information
Key concepts: Alemtuzumab, Renal transplant, Medicine, Immunology, Antibody, Induction therapy, Transplantation, Internal medicine